Presenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.
Stephen Bamford
Advertisement
Head of Clinical Data Standards & Transparency, The Janssen Pharmaceutical Companies of Johnson & Johnson
Articles by Stephen Bamford
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Role of Clinical Research Professionals: From Early Discovery to Phase III Success
2
Continuous Glucose Monitoring in Diabetes Clinical Trials: Endpoints, Regulatory Guidance, and Operational Best Practices
3
AI Can Draft the CSR Faster, But Does That Make Drug Development Faster?
4
What Smaller Biotechs Need to Get Right in Their First APAC Phase III Trial
5